Aortech Share Discussion Threads

[4x4guru] 24/5/2018 09:55

I for one are now more cautious about this stock, plus its my largest holding, it has a great potential in share price but recent activity and financials makes me think the share price could drop a bit lower due to increase risk. I can't work out how much money they are burning and what rate...?

[k1ngkonggb] 23/5/2018 19:38

Yep, I concur with your views. I do think this time they have the right management with excellent pedigree. Just a case of being a tad longer.

[smcl] 23/5/2018 19:26

Yes- I will review. It’s not without risk. But agree with STUG/Stuck the rewards could be massive. High risk though and no advice intended. Be prepared to lose but...

[k1ngkonggb] 23/5/2018 19:05

Ok....each to their own. Will you be partaking in some additional shares then?

[smcl] 23/5/2018 18:53

Can’t stand that ignorant STUG/Stuck

[smcl] 23/5/2018 18:52

For some time I might add!

[smcl] 23/5/2018 18:51

Yes- 25000.

[k1ngkonggb] 23/5/2018 18:42

smcl.....do you hold shares in AOR?

[smcl] 23/5/2018 18:26

STUG/ Stuck- .... pyc pyc pyc???

[smcl] 23/5/2018 18:25

Clueless wonder as opposed to chin less wonder although conceivably he could be both!!!

Ha ha ha ha that’s funny

[smcl] 23/5/2018 18:24

Yeh like STUG/Stuck the ramper extraordinaire

[cocker] 23/5/2018 18:05

down 7.8% today. Try looking on the bright side, you could have been a PYC holder.

[mustau] 23/5/2018 16:43

Thanks bones, makes sense.

[bones] 23/5/2018 15:02

mustau, you should get two offers, one for your 3 for 10 (30% of your holding) and another option to ask for as many as you want in excess shares (what you get depends on whether any open offer people decline to buy their own.

[mustau] 23/5/2018 13:25

Seems I’ve been offered a lot more than expected in my t account.

[the stigologist] 23/5/2018 01:38

I think some of the small scale odd-lot selling is people selling at 37p odd to buy/take up their open offer entitlements.

Can't understand that myself, this is such a good deal that people who understand the story would be putting new money to work.

Each to their own I guess.

[fillspectre] 22/5/2018 22:43

Lots of big claims made about this Company on this board but does anyone know how many customers are asking Biomerics specifically for Elast-Eon™ material. I mean are sales rising consistently. "The revenues generated by its licensing model cover the Company's current corporate costs.". Shouldn't these revenues more than cover the corporate costs next year? Fils

[the stigologist] 22/5/2018 22:30

Yes. Anyway looking forward to the double top on this chart :-D

[bones] 22/5/2018 21:35

The Stig - true. Increasing liquidity to 14m shares is a start but only that.I hope Stockdale pick up a few decent placees in this round.

[the stigologist] 22/5/2018 21:26

I suspect the CEO has bigger fish to fry than retail PIs to be honest. Should be courting smart money Institutions who invest in the small/mid cap world and will provide the supportive shareholder base from which Company can continue to build for the future.

[bones] 22/5/2018 21:19

Coolhandfluke, your question needs to be directed at Bill Brown. Why don't you email him now that the intentions have been made public? Hopefully he would put you right about the balance of reward to be earned by the tie ups with the development cos. There's an AGM later in the summer too. Ask about it there.The EMI option clause meaning that 30% won't vest until £3 a share tells me plenty. None of these directors is on much of a salary either. £120k pa for the main CEO is pretty thin gruel even in the microcap world.

[the stigologist] 22/5/2018 21:09

By the way my very good mate just happens to be a Cardiac specialist who regularly consults to EW and others. He is the one who described one of the new NEDs as 'a legend'. If AorTech deliver they will have no trouble gaining 'mindshare' with multi-billion dollar companies.

[the stigologist] 22/5/2018 20:58

Good spot bones

I pity the fool who thinks 300p (Mkt Cap c.£50m) is the sum total of the ambitions here

£100 per share is the all-time high (i.e. would be a £1.4bn market cap)

For anyone who thinks that is 'absurd'

MDT Medtronic Mkt Cap $115bn
ABT Abbot Labs (St Judes Medical) Mkt Cap $106bn
BSX Boston Scientific Mkt Cap $41bn
EW Edwards Lifesciences Mkt Cap $29bn

[coolhandfluke] 22/5/2018 19:58

I don't see the excitement for the future of Aortech. I see the partnerships making money, providing services, for as long as AOR can afford to pay. All companies sight the value of the markets they operate in, penetrating it is another matter. I hope I'm wrong but if the price ever gets back to my buy in price of 55p I will be out.